Real Time Screeners Intraday Screeners now on Real Time Data (Updated every 5 mins)
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Fundamental Analysis of AstraZenca Pharma India (ASTRAZEN)

Summary    Balance Sheet    Cash Flow    Income    Qtrly Income    Risk    Profitability    Qtrly Profit    Solvency    

You can now fully customise Watchlist by choosing any combination of your favorites Technical And Fundamental parameter.

Financial Highlights ASTRAZEN

EOD Close 2693.65
Market Cap 5992.28
EBITDA 109.55
Book Value 131.922
Profit margin 0.088
Qtr Revenue Growth YOY 0.0400
Qtr Earning Growth YOY -0.082
Revenue TTM 827.21
Gross Profit TTM 490.48
Revenue Per Share TTM 330.81
Face Value 2.00
Enterprise Value 0
Outstanding Shares 2.50
Consensus Target 0

Key Ratios of ASTRAZEN

Earning /Share 28.98
Diluted EPS TTM 28.98
PE Ratio 83.13
Div / Share 2.00
Div Yield % 0.080
PEG Ratio 0
Trailing PE 0
Forward PE 0
Price Sales TTM 0
Price Book MRQ 0
Enterprise Value / Revenue 0
Enterprise Value / EBITDA 0
Return on Asset TTM 0
Return on Equity TTM 0

Key Balance Sheet Fields

Period 31_Mar_2019 31-Mar-18 Growth
Common Stock 5.00 5.00 0 %
Current Liabilities 258.98 206.95 25.14 %
Total Liabilities 261.00 213.61 22.19 %
Current Assets 404.72 320.92 26.11 %
Total Assets 561.80 460.54 21.99 %
Working capital 145.74 113.97 27.88 %
Accounts Payable 168.20 127.20 32.23 %
Inventory 118.10 113.15 4.37 %
Net Receivable 86.12 59.41 44.96 %
   
   

Key Cash Flow Fields

Period 31_Mar_2019 31_Mar_2018 Growth
Cash EPS 13.87 8.13 70.60 %
Cash From Investment Activity 4.28 -9.36 145.73 %
Cash From Financial Activity 0 0 � %
Cash Operational Activity 54.98 8.79 525.48 %
Net Cash Flow 59.26 -0.570 10496.49 %
NetIncome 54.45 25.91 110.15 %
Capital Expenditure 18.69 6.28 197.61 %
Change To Inventory -4.96 -55.44 91.05 %
   
   



Annual Key Income Statement of ASTRAZEN

Period 31_Mar_2019 31_Mar_2018 Growth
Net Income From Continuing Ops 54.45 25.91 110.15 %
Net Income 54.45 25.91 110.15 %
Operating Income 56.57 34.54 63.78 %
Total Revenue 728.29 571.00 27.55 %
Operating Expense 671.72 536.46 25.21 %
Interest Expense 0 0 � %
Tax Expense 18.22 17.89 1.84 %
Income Before tax 72.67 43.80 65.91 %
Gross Profit 490.48 385.15 27.35 %
Dividend Paid 0 0 � %
   
   

Quarterly Key Income Statement of ASTRAZEN

Period 31_Dec_2019 30_Sep_2019 Growth
Net Income From Continuing Ops 26.70 14.42 85.16 %
Net Income 26.70 14.42 85.16 %
Operating Income 31.99 28.92 10.62 %
Total Revenue 223.86 208.48 7.38 %
Operating Expense 191.87 179.56 6.86 %
Interest Expense -0.271 -0.284 4.58 %
Tax Expense 8.48 17.38 51.21 %
Income Before tax 35.18 31.80 10.63 %
Gross Profit 142.55 134.33 6.12 %
Dividend Paid 0 0 � %
   
   




About Financial Data , All results are consolidated, Values are in Crores, Sourced from external Vendors


( Intraday Analysis is on Real Time Data (Updated every 5 Mins). All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)


All Rights Reserved By Mintnovate Market Research Pvt Ltd.